Opinion
Innovative challengers are building compliance into their DNA and outcompeting established players.
Michael Carbonara
Michael Carbonara is the CEO of Ibanera and a business leader with experience navigating complex regulatory environments and establishing licenses globally. Michael is also a board member at Organicell Regenerative Medicine, Inc., and is the Co-Founder of Gattaca Genomics.
One thing disruptor banks didn’t expect to be challenging: Compliance